Xphozah® (tenapanor)
for Kidney Disease

Xphozah (tenapanor) is the first FDA-approved phosphate absorption inhibitor, used twice daily to lower serum phosphorus levels in chronic kidney disease (CKD) patients on dialysis when phosphate binders are ineffective or intolerable. It blocks phosphate absorption in the gut.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Kidney Disease